Amilis operates a unified reproductive healthcare platform connecting patients, clinicians, and diagnostics in the UK. This integrated system streamlines care delivery for women's health and fertility services. The platform also builds a foundation for advancing future reproductive medicine through longitudinal data aggregation.
Funding
Funding not disclosed
Founders
Product
Problem
Many women lack sufficient information and resources to proactively manage their fertility and make informed decisions about options like egg freezing. Navigating fertility assessments, hormone testing, and clinic selection can be overwhelming and expensive, leading to delays and uncertainty.
Solution
Amilis is a digital platform designed to empower women to take control of their reproductive health journey. The platform provides personalized fertility assessments to help women understand their current status and future options. Amilis offers affordable hormone testing with clear, easy-to-understand results, including potential egg-freezing success rates. The platform also provides access to a network of pre-vetted fertility clinics, offering cost estimates and free initial consultations to help women make informed choices.
Target Audience
The primary target audience is women who are considering egg freezing or other fertility treatments and want to make informed decisions about their reproductive health.
Features
- Personalized fertility assessments based on individual history, concerns, and future plans.
- Affordable hormone testing options across the UK with clear analysis of results.
- Matching with pre-vetted fertility clinics based on individual needs and preferences.
- Access to unlimited free initial consultations with top egg-freezing clinics.
- Digital reproductive health wallet to track treatments and access guidance.
- Science-backed insights on fertility decline, egg freezing, and IVF success rates.
- LGBTQ+ friendly clinic search filter.